d-alpha tocopherol has been researched along with aclarubicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belianskaia, IV; Griaznova, NS; Navashin, SM; Petiushenko, RM; Saburova, LA; Sazykin, IuO | 1 |
| Nwankwoala, RN; West, WL | 1 |
| Maitani, Y; Takayama, K; Wang, J | 1 |
3 other study(ies) available for d-alpha tocopherol and aclarubicin
| Article | Year |
|---|---|
[Incorporation of an antineoplastic drug aclarubicin into liposomes in relation to the conditions of its encapsulation].
Topics: Aclarubicin; Cholesterol; Commonwealth of Independent States; Drug Carriers; Drug Industry; Drug Stability; Emulsions; Liposomes; Phosphatidylcholines; Stearic Acids; Technology, Pharmaceutical; Vitamin E | 1992 |
Inhibition of alpha-tocopherol and calcium calmodulin-stimulated phosphodiesterase activity in vitro by anthracyclines.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Brain; Calmodulin; Cattle; Daunorubicin; Doxorubicin; Male; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Vitamin E | 1988 |
Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Antioxidants; Cholesterol; Drug Carriers; Emulsions; Histiocytoma, Benign Fibrous; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Mice; Mice, Inbred C57BL; Particle Size; Polyethylene Glycols; Tumor Cells, Cultured; Vitamin E | 2002 |